We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,704
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMBR
7676
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$2K ﹤0.01%
1
-4
-80% -$13.5K
QTNT
7677
DELISTED
Quotient Limited Ordinary Shares
QTNT
$2K ﹤0.01%
+7
New +$1.64K
AIIQ
7678
DELISTED
AI Powered International Equity ETF
AIIQ
$2K ﹤0.01%
+100
New +$2.5K
BDR
7679
DELISTED
Blonder Tongue Laboratories Inc
BDR
$2K ﹤0.01%
2,175
+2,172
+72,400% +$2.32K
RESN
7680
DELISTED
Resonant Inc.
RESN
$2K ﹤0.01%
400
-567
-59% -$2.58K
ADXS
7681
DELISTED
Advaxis Inc
ADXS
$2K ﹤0.01%
67
+27
+68% +$699
SQBG
7682
DELISTED
Sequential Brands Group, Inc.
SQBG
$2K ﹤0.01%
22
+4
+22% +$304
DRIOW
7683
DELISTED
DarioHealth Corp. Warrant
DRIOW
$2K ﹤0.01%
17,522
+2,393
+16% +$588
SCIJ
7684
DELISTED
Global X Scientific Beta Japan ETF
SCIJ
$2K ﹤0.01%
51
+1
+2% +$31
PMOM
7685
DELISTED
Principal Sustainable Momentum Index ETF
PMOM
$2K ﹤0.01%
80
+79
+7,900% +$2.19K
TRPX
7686
DELISTED
Therapix Biosciences Ltd.
TRPX
$2K ﹤0.01%
473
-2,427
-84% -$11K
SRTSW
7687
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$2K ﹤0.01%
1,645
+100
+6% +$97
CORV
7688
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$2K ﹤0.01%
600
BVXVW
7689
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$2K ﹤0.01%
+1,303
New +$1.7K
LBDC
7690
DELISTED
2Leveraged Long ETRACS Wells Fargo Business Development Company Index ETN Series B due May 24 2041
LBDC
$2K ﹤0.01%
+143
New +$2.16K
CSS
7691
DELISTED
CSS Industries, Inc.
CSS
$2K ﹤0.01%
117
-1,459
-93% -$24.6K
EGI
7692
DELISTED
Entre Resources Ltd. Common Shares
EGI
$2K ﹤0.01%
4,066
-2,683
-40% -$1.03K
WYDE
7693
DELISTED
ProShares CDS Short North American HY Credit ETF
WYDE
$2K ﹤0.01%
54
UQM
7694
DELISTED
UQM Technologies, Inc.
UQM
$2K ﹤0.01%
1,892
-81,409
-98% -$91.7K
BORN
7695
DELISTED
China New Borun Corporation
BORN
$2K ﹤0.01%
1,009
-5,153
-84% -$6.62K
CBK
7696
DELISTED
Christopher & Banks Corporation
CBK
$2K ﹤0.01%
1,777
-5,111
-74% -$5.14K
EAGLU
7697
DELISTED
Platinum Eagle Acquisition Corp. Unit
EAGLU
$2K ﹤0.01%
150
-1,000
-87% -$10.2K
HQCL
7698
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$2K ﹤0.01%
386
-844
-69% -$5.91K
FANZ
7699
DELISTED
ProSports Sponsors ETF
FANZ
$2K ﹤0.01%
87
-445
-84% -$10K
DTRM
7700
DELISTED
Determine, Inc. Common Stock
DTRM
$2K ﹤0.01%
+1,197
New +$1.89K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,704 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.